Printer Friendly

Printed from http://www.researchandmarkets.com/reports/2081767

Abbott India Limited (ABBOTINDIA) - Financial and Strategic SWOT Analysis Review

Description:
Abbott India Limited (ABBOTINDIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by The publisher to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Abbott India Limited (AIL), a subsidiary of Abbott Laboratories, is an Indian pharmaceutical company that discovers, develops, manufactures and markets pharmaceutical, diagnostic, and nutritional and hospital products. AIL offers both OTC and prescription drugs in various formulations including tablets, liquids, injectibles and capsules, and nutritional products including powder. The company’s products cover various therapeutic areas including women’s health, thyroid disorders, depression, epilepsy, sleep disorders and diabetes. AIL provides healthcare solutions through four business units: Primary Care, which offers products in the areas of pain management, gastroenterology, through brands such as Brufen, Digene, Cremaffin; Specialty Care – Metaboloics and Urology, provides solutions in the areas of Thyroid, Obesity, Diabetes and Benign Prostratic Hyperplasia; Specialty Care – Neuroscience, has a broad portfolio, with specialty products in the Neurology and Psychiatric segments; and Hospital Care, provides products in the field of anesthesiology and neonatology through brands such as Forane, Sevorane and Survanta. AIL is headquartered in Mumbai, India.

Abbott India Limited Key Recent Developments

Dec 24, 2013: Abbott India Appoints Valentine Yien As Additional Director
Dec 24, 2013: Abbott India Announces Board Changes
Nov 07, 2013: Abbott India Announces Resignation Of Thomas Joseph Dee From Board
Nov 07, 2013: Abbott India Announces Change in Accounting Year
Nov 07, 2013: Abbott India Reports Revenue Of Approximately INR4.6 Billion For Quarter Ended 30 September 2013

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company
 
Contents:
List of Tables

List of Figures

Section 1 - About the Company

Abbott India Limited - Key Facts

Abbott India Limited - Key Employees

Abbott India Limited - Key Employee Biographies

Abbott India Limited - Major Products and Services

Abbott India Limited - History

Abbott India Limited - Company Statement

Abbott India Limited - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Joint Venture

Section 2 – Company Analysis

Abbott India Limited - Business Description

Abbott India Limited - Corporate Strategy

Abbott India Limited - SWOT Analysis

SWOT Analysis - Overview

Abbott India Limited - Strengths

Strength - Extensive Product Portfolio

Strength - Synergy Through Abbott Laboratories

Strength - Partnerships and Collaborations

Abbott India Limited - Weaknesses

Weakness - Lawsuits

Abbott India Limited - Opportunities

Opportunity - Focus on Product Development

Opportunity - Growth Prospects: Indian Pharmaceuticals Market

Opportunity - Strategic Initiatives

Abbott India Limited - Threats

Threat - Stringent Government Regulations

Threat - Intense Competition

Threat - Uncertain R&D Outcomes

Abbott India Limited - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Abbott India Limited, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015

Abbott India Limited, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015

Abbott India Limited, Recent Deals Summary

Section 5 – Company’s Recent Developments

Aug 28, 2014: USIBC Concludes Successful Medical Device Mission to India

Aug 14, 2014: Abbott India Reports Revenue Of INR5.3 Billion For Quarter Ended 30 June 2014

May 28, 2014: Abbott India Reports Revenue Of INR4.9 Billion For Quarter Ended 31 March 2014

Feb 08, 2014: Abbott India Reports Revenue Of Approximately INR4.9 Billion For Quarter Ended 31 December 2013

Section 6 – Appendix

Methodology

Ratio Definitions

About Us

Contact Us

Disclaimer

List of Tables

Abbott India Limited, Key Facts

Abbott India Limited, Key Employees

Abbott India Limited, Key Employee Biographies

Abbott India Limited, Major Products and Services

Abbott India Limited, History

Abbott India Limited, Other Locations

Abbott India Limited, Joint Venture

Abbott India Limited, Key Competitors

Abbott India Limited, Ratios based on current share price

Abbott India Limited, Annual Ratios

Abbott India Limited, Interim Ratios

Abbott India Limited, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015

Abbott India Limited, Pharmaceuticals & Healthcare, Deals By Type, 2009 to YTD 2015

Abbott India Limited, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

Abbott India Limited, Performance Chart (2011 - 2015)

Abbott India Limited, Ratio Charts

Abbott India Limited, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015

Abbott India Limited, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
 
Ordering:
Order Online - visit http://www.researchandmarkets.com/reports/2081767

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Page 1 of 2
Printed Aug 28, 2015
3:42:23 AM

Fax order form

To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net

Order information

Please verify that the product information is correct and select the format you require.

Product name

Abbott India Limited (ABBOTINDIA) - Financial and Strategic SWOT Analysis Review

Web Address

http://www.researchandmarkets.com/reports/2081767

Office Code

SC

 

Report Formats

Please enter the quantity of the report format you require.

Format Quantity Price
Electronic (PDF) - Single User USD 125
Electronic (PDF) - Site License USD 250
Electronic (PDF) - Enterprisewide USD 375

Contact information

Please enter all the information below in block capitals.

Title:
Mr Mrs Dr Miss Ms Prof
First Name:
Last Name:
Email Address:
Job Title:
Organisation:
Address:
City:
Postal / Zip Code:
Country:
Phone Number:
Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2
Printed Aug 28, 2015
3:42:23 AM

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

You will receive an email with a link to a secure page to enter your credit card details.

 
Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

 
Pay by Wire Transfer:

Please transfer funds to:

Account Number:
83313083
Sort Code:
98-53-30
Swift Code:
ULSBIE2D
IBAN Number:
IE78ULSB98533083313083
Bank Address:
Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.
 

If you have a Marketing Code please enter it below:

Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)